Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality

Area of Science:

• Endocrinology
• Bone Metabolism
• Women's Health

Background:

• Menopause is associated with decreased bone mineral density and libido.
• Hormone replacement therapy (HRT) is used to manage menopausal symptoms.
• The role of androgens in postmenopausal bone health and sexuality requires further investigation.

Purpose of the Study:

• To investigate the long-term effects of estradiol and testosterone implants on bone mineral density (BMD) and sexuality in postmenopausal women.
• To compare the efficacy of estradiol implants alone versus combined estradiol and testosterone implants.

Main Methods:

• Prospective, 2-year, single-blind randomized trial.
• Thirty-four postmenopausal volunteers received either estradiol (E) or estradiol plus testosterone (E&T) implants.
• Bone mineral density measured by DEXA; sexuality assessed using the Sabbatsberg sexual self-rating scale.

Main Results:

• Both E and E&T groups showed significant increases in BMD at all measured sites.
• The E&T group demonstrated a significantly greater increase in BMD compared to the E group.
• All sexual parameters improved significantly in both groups, with greater improvements in the E&T group for activity, satisfaction, pleasure, orgasm, and relevancy.
• Total body fat-free mass increased significantly in the E&T group only.
• Lipid profiles (total cholesterol, LDL-cholesterol) improved in both groups.

Conclusions:

• Combined estradiol and testosterone implants are more effective than estradiol alone in increasing BMD in postmenopausal women.
• Testosterone therapy significantly enhances sexual function and libido in postmenopausal women.
• Combined therapy offers a beneficial treatment option for postmenopausal women, improving bone health, sexual well-being, and body composition.